Related Experiment Video
Updated: Jul 10, 2026
09:07
In Vitro Model for Studying Differentiation and Changes of Multi-Omics on Murine Airway Epithelial Cells Stimulated with Cigarette Smoke Extract
Published on: July 12, 2024
Squamous metaplasia amplifies pathologic epithelial-mesenchymal interactions in COPD patients
Jun Araya1, Stephanie Cambier, Jennifer A Markovics
1Department of Pathology, Lung Biology Center, UCSF, San Francisco, California 94110, USA.
The Journal of Clinical Investigation
|October 30, 2007
Summary
Squamous metaplasia (SM) in smokers drives airway wall thickening in chronic obstructive pulmonary disease (COPD) by increasing IL-1beta and activating TGF-beta. This highlights TGF-beta as a potential therapeutic target for COPD.
Area of Science:
- Pulmonary Medicine
- Cell Biology
- Immunology
Background:
- Squamous metaplasia (SM) is prevalent in smokers and linked to airway obstruction in chronic obstructive pulmonary disease (COPD).
- Small airway wall thickening is a key factor in COPD-related airway obstruction.
- The role of SM in promoting airway wall thickening via epithelial-mesenchymal interactions in COPD requires elucidation.
Purpose of the Study:
- To investigate whether squamous metaplasia (SM) actively contributes to small airway wall thickening in COPD.
- To explore the mechanisms underlying SM-induced airway wall thickening, focusing on epithelial-mesenchymal interactions.
- To identify potential therapeutic targets for COPD based on these mechanisms.
Main Methods:
- Immunohistochemical staining, airway morphometry, and fibroblast culture using lung samples from COPD patients.
- Genome-wide analysis of an in vitro model of SM.
- In vitro modeling of human airway epithelial-mesenchymal interactions.
Main Results:
- SM increases IL-1beta secretion, inducing a fibrotic response in adjacent airway fibroblasts.
- Integrin-mediated TGF-beta activation plays a crucial role in amplifying SM and driving IL-1beta-dependent profibrotic mesenchymal responses.
- SM severity correlates with COPD severity, and fibroblast alpha(v)beta(8) expression correlates with disease severity and small airway wall thickening.
Conclusions:
- Squamous metaplasia actively contributes to airway wall thickening in COPD.
- The IL-1beta and TGF-beta signaling pathway, mediated by integrin alpha(v)beta(8), is a key mechanism driving fibrosis in COPD airways.
- Targeting TGF-beta presents a promising therapeutic strategy for COPD.
Related Concept Videos
01:24Cellular Adaptation IV: Dysplasia and Metaplasia
DysplasiaDysplasia refers to abnormal changes in the size, shape, and organization of mature cells, characterized by pleomorphism, nuclear abnormalities, and increased mitotic activity. It commonly affects epithelial tissues, including the cervix, gastrointestinal tract, respiratory mucosa, and endometrium. Although it may occur alongside hyperplasia, dysplasia is not a true adaptive response but a preneoplastic change with potential to progress to cancer.When confined above the basement...
01:24Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
01:23Chronic Obstructive Pulmonary Disease II: Emphysema
Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
01:20COPD: Pathogenesis and Clinical Features
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
01:19Chronic Obstructive Pulmonary Disease IV: Clinical Manifestations
Chronic Obstructive Pulmonary Disease, or COPD, is a long-term condition marked by persistent and only partially reversible airflow limitation. It involves two overlapping conditions—chronic bronchitis and emphysema—which often co-appear but differ in dominant symptoms and underlying mechanisms.Chronic Bronchitis FeaturesChronic bronchitis presents with a persistent productive cough and thick, sometimes purulent mucus due to airway inflammation, enlarged mucus glands, and goblet cell...